In response to the global spread of COVID-19, researchers worldwide rapidly began gathering evidence to better understand the virus and the disease it causes.
While scientific knowledge about the virus is incomplete, data and evidence is accumulating rapidly, with research investigating the spread of the virus, as well as effective approaches to manage and treat COVID-19. Given the evolving nature of this ongoing global pandemic, there is a need to synthesise the evidence to maximise the insights that can be gained from this increasing pool of data.
Recognising this need, Hungarian company Epidy Health Research Ltd developed an online evidence synthesis platform and risk assessment tool for factors associated with the development and prognosis of COVID-19. Their platform brings together up-to-date evidence to provide information summaries, as well as using the data to inform a risk assessment tool that can evaluate risk of SARS-CoV-2 infection and development of COVID-19. However, the company needed help with user interface development, data management and GDPR.
To facilitate this, EIT Health introduced Epidy Health Research Ltd to Ententee, a software development company based in the Czech Republic. Ententee, who had the skills that Epidy were looking for, were keen to leverage their knowledge and expertise to help in the fight against COVID-19. The two companies are now exploring ways they can further develop the platform together.
Share this page
